I want to study the effect of a particular transcription factor on activation and proliferation of B lymphocytes. My aim is to knock-down or knock out the transcript in primary B lymphocytes (hard-to transfect), stimulate with anti-IgM antibody and measure proliferation with thymidine incorporation assay. Please share your experiences and expert views if shRNA or CRISPR/Cas9 should be a better choice for this kind of experiment.
(Please note that I have access to P2 lab, so that's not a problem)
Thanks in advance